Filana Therapeutics, Inc.
FLNA
Filana Therapeutics, Inc. (formerly Cassava Sciences, Inc.) is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to develop transformative medicines to improve the lives of patients with central nervous system (CNS) disorders, such as Tuberous Sclerosis Complex (TSC)-related epilepsy and other diseases associated with dysregulation or overexpression of filamin A.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$42M
▼ -273.7% YoY
Op. Margin
–
ROIC
-54.30%
▲ +10.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$29M
▲ +71.9% YoY
Op. Cash Flow (TTM)
-$29M
▲ +72.4% YoY
Net Debt
-$47M
Net Cash Position
Cash & Equiv.
$47M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with FLNA
Held by ETFs
FLNA is in 2 US ETFs. The largest of them, with FLNA's weight in each:
Filana Therapeutics (FLNA) in three numbers
Questions about Filana Therapeutics
Is Filana Therapeutics a high-quality business?
Filana Therapeutics scores 40 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 6 checks computed from SEC filings. Its best check is revenue growth at 34.7%, and its weakest is return on capital at -54.3%. The Quality tab shows every check against its target.
Does Filana Therapeutics (FLNA) pay a dividend?
No. Filana Therapeutics (FLNA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 2 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in FLNA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing FLNA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.